UnitedHealth Group Incorporated $UNH Stock Holdings Reduced by Neville Rodie & Shaw Inc.

Neville Rodie & Shaw Inc. trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 26.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,918 shares of the healthcare conglomerate’s stock after selling 3,881 shares during the quarter. Neville Rodie & Shaw Inc.’s holdings in UnitedHealth Group were worth $3,770,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently added to or reduced their stakes in the business. Rydar Equities Inc. bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at $729,000. Summit Financial Wealth Advisors LLC raised its holdings in UnitedHealth Group by 55.2% during the second quarter. Summit Financial Wealth Advisors LLC now owns 3,820 shares of the healthcare conglomerate’s stock valued at $1,192,000 after buying an additional 1,359 shares in the last quarter. National Wealth Management Group LLC bought a new stake in shares of UnitedHealth Group during the 2nd quarter worth about $706,000. Caldwell Trust Co bought a new position in shares of UnitedHealth Group in the 2nd quarter valued at approximately $4,520,000. Finally, Canal Capital Management LLC boosted its position in UnitedHealth Group by 20.4% during the second quarter. Canal Capital Management LLC now owns 1,407 shares of the healthcare conglomerate’s stock worth $439,000 after purchasing an additional 238 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 0.1%

Shares of UNH stock opened at $341.46 on Tuesday. The stock has a market cap of $309.31 billion, a P/E ratio of 17.82, a price-to-earnings-growth ratio of 2.23 and a beta of 0.43. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.82. The stock has a fifty day moving average price of $339.49 and a 200 day moving average price of $317.51. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $606.36.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same quarter last year, the company earned $7.15 earnings per share. The company’s revenue for the quarter was up 12.2% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio is currently 46.14%.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. Cantor Fitzgerald restated an “overweight” rating and issued a $440.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Weiss Ratings upgraded shares of UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 24th. TD Cowen boosted their price objective on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research report on Thursday, October 30th. Barclays lifted their price target on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Finally, Zacks Research upgraded shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Seventeen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Hold” and a consensus price target of $385.54.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.